Translational Research and Global Collaboration in Preventive Oncology
Global collaboration and translational research are essential to advance preventive oncology and implement innovations in early cancer detection worldwide. Translational research bridges basic scientific discoveries with clinical application, ensuring that biomarkers, diagnostic tools, and preventive interventions are validated, scalable, and effective across diverse populations. Multi-center studies, cohort analyses, and real-world data integration accelerate the development of evidence-based strategies. International collaboration supports standardization of screening protocols, data sharing, and harmonization of laboratory and diagnostic practices, enhancing reproducibility and reliability. The session emphasizes capacity building, training programs, and knowledge transfer to expand access to cutting-edge preventive technologies in low- and middle-income regions. Ethical and regulatory harmonization, including informed consent, data privacy, and equitable benefit-sharing, is central to global implementation. Policy frameworks, financing models, and public-private partnerships are critical to sustaining large-scale prevention initiatives. By integrating scientific innovation, health systems strengthening, and international cooperation, translational research accelerates the adoption of preventive oncology tools and ensures that the benefits of early detection and personalized prevention reach populations worldwide, reducing cancer burden and improving global health equity.